F11a and FX12a Inhibitors – the Next Wave of Novel Anticoagulants?
Anticoagulation treatment has been revolutionised in the past few decades with the development of drugs that increasingly target individual components of the coagulation cascade. Yet... Read More
Time is Right for Restrictive Transfusion Strategy in ECMO
Despite studies supporting a restrictive red cell transfusion strategy in many medical situations, a more liberal strategy is still widely used in patients who need... Read More
Meta-Analysis Backs up TXA Safety in Patients at Risk of Thrombosis
Tranexamic acid (TXA) is safe to use to prevent bleeding in patients at the time of surgery, even in those at risk of thrombosis, according... Read More
Measuring the Success of PBM in Practice – Lessons from Spain
According to the World Health Organisation, widespread implementation of patient blood management (PBM) programmes remains an urgent need.1 It is also important to evaluate how... Read More
Diversity of PBM Reflected in Scientific Programme
There will be something for everyone in this year’s Scientific Programme, according to Sigismond Lasocki (University Hospital Angers, France), the Chair of the Scientific Committee.
“We tried to have not only a diversity of topics but also a diversity of speakers – both in terms of their home countries and in terms of their medical specialities,” says Lasocki.
Return to In-Person Event as NATA Celebrates its 25 th Anniversary!
Opening the Symposium and welcoming you to Athens will be NATA Chair Jens Meier (Kepler University Hospital, Linz, Austria). Meier will take a look at the evolution of PBM and how it has changed since NATA formed as an independent medical association in 1998. He will also highlight some of the changes that have occurred within NATA in the past couple of years.
Restrictive transfusion strategy after cardiac surgery.
Zeroual N, Blin C, Saour M, et al.
Anesthesiology 2021;134:370-380.
Review by H. B. Ravn
Obituary: Hans Gombotz (1948–2021)
After a long battle with cancer and in his 73rd year, Professor Hans Gombotz passed away on September 13, 2021. We are mourning over the... Read More
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study.
COVIDSurg Collaborative; GlobalSurg Collaborative
Anaesthesia 2022;77:28-39.
Review by C. M. Samama
Viscoelastic haemostatic assay augmented protocols for major trauma haemorrhage (ITACTIC): a randomized, controlled trial.
Baksaas-Aasen K, Gall LS, Stensballe J, et al.
Intensive Care Med 2021;47:49-59.
Review by D. Faraoni
Preoperative intravenous iron to treat anaemia before major abdominal surgery (PREVENTT): a randomised, double-blind, controlled trial.
Richards T, Rao Baikady R, Clevenger B, et al.
Lancet 2020;396:1353-1361
Review by J. Meier
Routine venous thromboembolism prophylaxis may be inadequate in the hypercoagulable state of severe coronavirus disease 2019.
Maatman TK, Jalali F, Feizpour C, et al.
Crit Care Med 2020;48:e783-e790.
Review by C. M. Samama
Effect of hydroxyethyl starch vs saline for volume replacement therapy on death or postoperative complications among high-risk patients undergoing major abdominal surgery: the FLASH randomized clinical trial.
Futier E, Garot M, Godet T, et al.
JAMA 2020;323:225-236.
Review by J. Meier
Fibrinogen concentrate to cardiac surgery patients with ongoing bleeding does not increase the risk of thromboembolic complications or death.
Waldén K, Jeppsson A, Nasic S, Karlsson M
Thromb Haemost 2020;120:384-391.
Review by H. B. Ravn
Effects of iron isomaltoside vs ferric carboxymaltose on hypophosphatemia in iron-deficiency anemia: two randomized clinical trials.
Wolf M, Rubin J, Achebe M, et al.
JAMA 2020;323:432-443.
Review by M. Auerbach